U.S. Pharmaceuticals & Biotech Strong Balance Sheet Stocks

LENZ Therapeutics

Market Cap: US$1.1b

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

Medpace Holdings

Market Cap: US$13.6b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Amylyx Pharmaceuticals

Market Cap: US$887.2m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

MacroGenics

Market Cap: US$122.6m

A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.

BioLife Solutions

Market Cap: US$1.2b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

ETHZilla

Market Cap: US$403.2m

A clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States.

Revolution Medicines

Market Cap: US$7.3b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Cytek Biosciences

Market Cap: US$506.4m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

Centessa Pharmaceuticals

Market Cap: US$2.1b

A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.

SAB Biotherapeutics

Market Cap: US$23.5m

A clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders.

Zevra Therapeutics

Market Cap: US$501.3m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Coeptis Therapeutics Holdings

Market Cap: US$57.3m

Operates as a biopharmaceutical company.

Lineage Cell Therapeutics

Market Cap: US$274.0m

A clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally.

Verastem

Market Cap: US$649.9m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Atai Life Sciences

Market Cap: US$977.4m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

INmune Bio

Market Cap: US$51.0m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

Tilray Brands

Market Cap: US$1.3b

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

Illumina

Market Cap: US$15.0b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Harvard Apparatus Regenerative Technology

Market Cap: US$30.6m

A clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects.

Alaunos Therapeutics

Market Cap: US$4.8m

A clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders.

Eton Pharmaceuticals

Market Cap: US$479.2m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Kura Oncology

Market Cap: US$705.7m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Adagene

Market Cap: US$100.9m

A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.

Viridian Therapeutics

Market Cap: US$1.5b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Repare Therapeutics

Market Cap: US$72.6m

A clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States.

CG Oncology

Market Cap: US$2.4b

A late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.

OmniAb

Market Cap: US$196.3m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

MoonLake Immunotherapeutics

Market Cap: US$3.8b

A clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.

Vistagen Therapeutics

Market Cap: US$111.1m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders.

AC Immune

Market Cap: US$212.7m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

Merus

Market Cap: US$5.0b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Wave Life Sciences

Market Cap: US$1.3b

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

Sionna Therapeutics

Market Cap: US$1.0b

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

ArriVent BioPharma

Market Cap: US$791.9m

A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

CollPlant Biotechnologies

Market Cap: US$33.2m

A regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.

Danaher

Market Cap: US$142.5b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.